Symptomatic hypoglycemia in a child with common variable immunodeficiency: Deficient anterior pituitary with variable immune deficiency (DAVID) syndrome

• Type: Article in International Scientific Journal
• Date: 2020

Authors

Nogueira, M (Author) Other; Pinheiro, M (Author) FMUP; Maia, R (Author) Other; Silva, RS (Author) FMUP; Costa, C (Author) FMUP; Campos, T (Author) Other; Leao, M (Author) Other; Vitor, AB (Author) Other; C Correia (Author) FMUP; Fontoura, M (Author) Other

Journal

The Journal is awaiting validation by the Administrative Services.

Title: Clinical Pediatric Endocrinology

ISSN: 0918-5739

Indexing

ISI Web of Knowledge - 1 Citation

Scopus - 1 Citation

Other information

Authenticus ID: P-00S-HS7

DOI: 10.1297/cpe.29.111

Abstract (EN): Deficient anterior pituitary with variable immune deficiency (DAVID) syndrome is a rare condition characterized by symptomatic ACTH deficiency and primary hypogammaglobulinemia, caused by pathogenic variants of the nuclear factor kappa-B subunit 2 (NF-kappa B2) gene. We report the case of a 9-yr-old boy diagnosed with common variable immunodeficiency at the age of 3, who is under monthly intravenous immunoglobulin. The patient was admitted twice to the pediatric emergency service at the age of 9 due to symptomatic hypoglycemic events. During the hypoglycemic crisis, serum cortisol was low (0.1 mu g/dL), ACTH level was inappropriately low (4.4 ng/L) and the ACTH stimulation test failed to raise the blood cortisol level. Pituitary magnetic resonance imaging showed a hypoplastic pituitary. Other pituitary deficiencies, primary hyperinsulinism and other metabolic diseases were excluded. He started hydrocortisone replacement treatment while maintaining immunoglobulin substitution and he remains asymptomatic. Molecular analysis revealed the heterozygous nonsense pathogenic variant, c.2557C T (Arg853Ter) in the NF-kappa B2 gene. Thus, symptomatic hypoglycemia in a child with primary immunodeficiency should raise the suspicion of DAVID syndrome, prompting NF-kappa B2 molecular analysis, to allow timely and appropriated therapy and genetic counseling.

Language: English

Type (Professor's evaluation): Dissemination